Cargando…

Development of clinical pharmacy services for intensive care units in Korea

OBJECTIVE: To be utilized for the development of pharmacists’ intervention service by determining factors which affect pharmacists’ prescription interventions. SETTING: Patients who were admitted to intensive care units (ICUs) in internal medicine departments in Korea. METHODS: Data including age, g...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jeong Mee, Park, So Jin, Sohn, You Min, Lee, Young Mee, Yang, Catherine Seonghee, Gwak, Hye Sun, Lee, Byung Koo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3901852/
https://www.ncbi.nlm.nih.gov/pubmed/24478944
http://dx.doi.org/10.1186/2193-1801-3-34
_version_ 1782300912761438208
author Kim, Jeong Mee
Park, So Jin
Sohn, You Min
Lee, Young Mee
Yang, Catherine Seonghee
Gwak, Hye Sun
Lee, Byung Koo
author_facet Kim, Jeong Mee
Park, So Jin
Sohn, You Min
Lee, Young Mee
Yang, Catherine Seonghee
Gwak, Hye Sun
Lee, Byung Koo
author_sort Kim, Jeong Mee
collection PubMed
description OBJECTIVE: To be utilized for the development of pharmacists’ intervention service by determining factors which affect pharmacists’ prescription interventions. SETTING: Patients who were admitted to intensive care units (ICUs) in internal medicine departments in Korea. METHODS: Data including age, gender, clinical departments, length of hospital stay, status of organ dysfunction, intervention status, frequently intervened drugs, and health care providers’ questions were prospectively collected in ICUs in the department of internal medicine in a tertiary teaching hospital from January to December, 2012. MAIN OUTCOME MEASURE: Primary outcome was factors which affect pharmacists’ prescription interventions. Secondary outcomes included frequencies of the intervention, intervention acceptance rates, intervention issues, and frequently intervened drugs. RESULTS: A total of 1,213 prescription interventions were made for 445 patients (33.1%) of the 1,344 patients that were analyzed. Length of hospital stay was significantly longer for the group that needed pharmacists’ interventions (p < 0.001). Pharmacists’ intervention requirements were significantly higher in patients with kidney dysfunction (p < 0.001). The percentage of intervention accepted was 96.8%, and interventions that were common were as follows (in order): clinical pharmacokinetic service, dosage or dosing interval changes, dosing time changes or dose changes, and total parenteral nutrition consultation. The five medications with the highest intervened frequency were (in order) vancomycin, famotidine, ranitidine, meropenem, and theophylline. CONCLUSION: The need for pharmacists’ prescription interventions was highest among patients with longer length of stay and patients with kidney dysfunction. Based on these findings, prescription intervention activities could be initiated with severely ill patients. The results could be utilized in countries which are planning to develop pharmacists’ intervention service.
format Online
Article
Text
id pubmed-3901852
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-39018522014-01-29 Development of clinical pharmacy services for intensive care units in Korea Kim, Jeong Mee Park, So Jin Sohn, You Min Lee, Young Mee Yang, Catherine Seonghee Gwak, Hye Sun Lee, Byung Koo Springerplus Research OBJECTIVE: To be utilized for the development of pharmacists’ intervention service by determining factors which affect pharmacists’ prescription interventions. SETTING: Patients who were admitted to intensive care units (ICUs) in internal medicine departments in Korea. METHODS: Data including age, gender, clinical departments, length of hospital stay, status of organ dysfunction, intervention status, frequently intervened drugs, and health care providers’ questions were prospectively collected in ICUs in the department of internal medicine in a tertiary teaching hospital from January to December, 2012. MAIN OUTCOME MEASURE: Primary outcome was factors which affect pharmacists’ prescription interventions. Secondary outcomes included frequencies of the intervention, intervention acceptance rates, intervention issues, and frequently intervened drugs. RESULTS: A total of 1,213 prescription interventions were made for 445 patients (33.1%) of the 1,344 patients that were analyzed. Length of hospital stay was significantly longer for the group that needed pharmacists’ interventions (p < 0.001). Pharmacists’ intervention requirements were significantly higher in patients with kidney dysfunction (p < 0.001). The percentage of intervention accepted was 96.8%, and interventions that were common were as follows (in order): clinical pharmacokinetic service, dosage or dosing interval changes, dosing time changes or dose changes, and total parenteral nutrition consultation. The five medications with the highest intervened frequency were (in order) vancomycin, famotidine, ranitidine, meropenem, and theophylline. CONCLUSION: The need for pharmacists’ prescription interventions was highest among patients with longer length of stay and patients with kidney dysfunction. Based on these findings, prescription intervention activities could be initiated with severely ill patients. The results could be utilized in countries which are planning to develop pharmacists’ intervention service. Springer International Publishing 2014-01-17 /pmc/articles/PMC3901852/ /pubmed/24478944 http://dx.doi.org/10.1186/2193-1801-3-34 Text en © Kim et al.; licensee Springer. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Kim, Jeong Mee
Park, So Jin
Sohn, You Min
Lee, Young Mee
Yang, Catherine Seonghee
Gwak, Hye Sun
Lee, Byung Koo
Development of clinical pharmacy services for intensive care units in Korea
title Development of clinical pharmacy services for intensive care units in Korea
title_full Development of clinical pharmacy services for intensive care units in Korea
title_fullStr Development of clinical pharmacy services for intensive care units in Korea
title_full_unstemmed Development of clinical pharmacy services for intensive care units in Korea
title_short Development of clinical pharmacy services for intensive care units in Korea
title_sort development of clinical pharmacy services for intensive care units in korea
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3901852/
https://www.ncbi.nlm.nih.gov/pubmed/24478944
http://dx.doi.org/10.1186/2193-1801-3-34
work_keys_str_mv AT kimjeongmee developmentofclinicalpharmacyservicesforintensivecareunitsinkorea
AT parksojin developmentofclinicalpharmacyservicesforintensivecareunitsinkorea
AT sohnyoumin developmentofclinicalpharmacyservicesforintensivecareunitsinkorea
AT leeyoungmee developmentofclinicalpharmacyservicesforintensivecareunitsinkorea
AT yangcatherineseonghee developmentofclinicalpharmacyservicesforintensivecareunitsinkorea
AT gwakhyesun developmentofclinicalpharmacyservicesforintensivecareunitsinkorea
AT leebyungkoo developmentofclinicalpharmacyservicesforintensivecareunitsinkorea